Steve Thorne

Steve Thorne

Company: KaliVir Immnuotherapeutics

Job title: CSO


The Design of Oncolytic Viral Therapies for Intravenous Delivery 11:45 am

• Next generation OV therapies will ideally be delivered intravenously • Modifications of the viral backbone can increase systemic delivery • Addition of therapeutic transgene combinations can create potent systemic therapiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.